Difference in efficacy between anti-PD-1 and anti-PD-L1 antibodies may be attributable to PD-1:PD-L2 complex inhibition, rather than differences in PD-1:PD-L1 inhibition Poster Difference in efficacy between anti-PD-1 and anti-PD-L1 antibodies may be attributable to PD-1:PD-L2 complex inhibition, rather than differences in PD-1:PD-L1 inhibition CertaraDecember 13, 2024
Cumulative drug binding to Cerebral Amyloid Angiopathy (CAA) predicts ARIA-E incidence for anti-Aβ antibodies in Alzheimer’s Disease Poster Cumulative drug binding to Cerebral Amyloid Angiopathy (CAA) predicts ARIA-E incidence for anti-Aβ antibodies in Alzheimer’s Disease CertaraDecember 13, 2024
QSP model of neuroinflammation: Effect of TREM2 stimulation on microglial activation and function in the context of Alzheimer’s disease Poster QSP model of neuroinflammation: Effect of TREM2 stimulation on microglial activation and function in the context of Alzheimer’s disease CertaraDecember 13, 2024
Population Pharmacokinetics (PopPK) of Revumenib in Patients with Relapsed/Refractory Acute Leukemias Poster Population Pharmacokinetics (PopPK) of Revumenib in Patients with Relapsed/Refractory Acute Leukemias CertaraDecember 12, 2024
Quantitative Systems Pharmacology (QSP) Summit 2025 Live Events Quantitative Systems Pharmacology (QSP) Summit 2025 The Quantitative Systems Pharmacology (QSP) Summit is a free conference dedicated to fostering an active…CertaraDecember 12, 2024
Delivering High-Quality, Timely Responses to EMA Safety Queries Case Study Delivering High-Quality, Timely Responses to EMA Safety Queries A pharmaceutical company approached us for support with eight safety-related queries from the European Medicines…CertaraDecember 12, 2024
Static Versus Dynamic Model Predictions of Competitive Inhibitory Metabolic Drug–Drug Interactions via Cytochromes P450: One Step Forward and Two Steps Backwards Publication Static Versus Dynamic Model Predictions of Competitive Inhibitory Metabolic Drug–Drug Interactions via Cytochromes P450: One Step Forward and Two Steps Backwards Predicting metabolic drug–drug interactions (DDIs) via cytochrome P450 enzymes (CYP) is essential in drug development,…CertaraDecember 12, 2024
Preclinical data exposures underpredict clinical physiologically active doses for bispecific T-cell engagers in solid tumors indications; are there better metrics? -insights from a small mechanistic MBMA Poster Preclinical data exposures underpredict clinical physiologically active doses for bispecific T-cell engagers in solid tumors indications; are there better metrics? -insights from a small mechanistic MBMA CertaraDecember 11, 2024
CMC Writing Support Helps Client Lift Clinical Hold Case Study CMC Writing Support Helps Client Lift Clinical Hold In drug development, Chemistry, Manufacturing, and Controls (CMC) regulatory writing plays a pivotal role in ensuring the…CertaraDecember 10, 2024
Piet van der Graaf on AI and AI-assisted approaches in drug discovery & development Video Piet van der Graaf on AI and AI-assisted approaches in drug discovery & development At the 2024 AAPS PharmSci 360 conference, Bioanalysis Zone interviewed Piet van der Graaf, Senior…CertaraDecember 10, 2024